Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Proliferative Diabetic Retinopathy”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Testing effectiveness (Phase 2)Study completedNCT01571232
What this trial is testing

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaNon-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Retina Macula Institute 20
Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Large-scale testing (Phase 3)Study completedNCT01853072
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 1

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 881
Post-approval studies (Phase 4)Ended earlyNCT00563628
What this trial is testing

Changes in Macular Thickness After Patterns Scan Laser

Who this might be right for
Non Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Asociación para Evitar la Ceguera en México 8
Testing effectiveness (Phase 2)Study completedNCT05409235
What this trial is testing

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Who this might be right for
Diabetic Retinopathy
OcuTerra Therapeutics, Inc. 225
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Testing effectiveness (Phase 2)UnknownNCT00849537
What this trial is testing

The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences
Testing effectiveness (Phase 2)Looking for participantsNCT07354477
What this trial is testing

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)
Qlaris Bio, Inc. 14
Testing effectiveness (Phase 2)Looking for participantsNCT07259928
What this trial is testing

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Who this might be right for
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB 12
Not applicableStudy completedNCT01607190
What this trial is testing

Biomarkers of Diabetic Retinopathy Progression

Who this might be right for
Type 2 Diabetes MellitusMild Nonproliferative Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 200
Post-approval studies (Phase 4)WithdrawnNCT04702048
What this trial is testing

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Who this might be right for
Retinopathy, Diabetic
University of Rochester
Testing effectiveness (Phase 2)Study completedNCT04424290
What this trial is testing

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 45
Post-approval studies (Phase 4)Enrolling By InvitationNCT06191094
What this trial is testing

Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyVitreous Hemorrhage Due to Diabetes Mellitus
University of Colorado, Denver 100
Not applicableLooking for participantsNCT06713720
What this trial is testing

Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyNon-Proliferative Diabetic RetinopathyRemote Ischemic Conditioning+2 more
Xuxiang Zhang, MD 68
Not applicableUnknownNCT01107132
What this trial is testing

Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusNon-Proliferative Diabetic RetinopathyDiabetic Macular Edema
Soroka University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT04692688
What this trial is testing

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more
Ocuphire Pharma, Inc. 103
Large-scale testing (Phase 3)UnknownNCT00908778
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Not applicableEnded earlyNCT01213888
What this trial is testing

Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
University of British Columbia 3
Load More Results